We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Draganfly Turn Medical Drone Delivery Into a Growth Opportunity?
Read MoreHide Full Article
Key Takeaways
Draganfly completed initial proof-of-concept flights for its Mass General Brigham delivery pilot.
Draganfly targets healthcare and emergency-response deliveries to hard-to-access locations.
Draganfly trades at 1X forward sales versus the industry's 2.10X, with shares down 28% in six months.
Draganfly (DPRO - Free Report) is exploring medical drone delivery as an application for its UAV technology, targeting the logistical challenges healthcare providers face. Drone-based delivery offers an alternative for transporting selected medical items between healthcare facilities and patients.
In January 2024, Draganfly announced an agreement with Mass General Brigham to pilot drone delivery services for its Home Hospital program. The initiative focused on developing delivery routes in the greater Boston area and evaluating how drones could support home-based care. Potential deliveries include critical medicines, technical equipment and laboratory materials. In December 2024, Draganfly announced the completion of initial proof-of-concept flights, marking an early step in assessing the technology’s potential for healthcare logistics.
Beyond hospital-based delivery, Draganfly also pursued medical drone applications in emergency and humanitarian settings. Its medical response technology has been associated with initiatives in Ukraine, where drones can help transport essential supplies to difficult-to-access locations. The company has also demonstrated medical delivery capabilities in an emergency-response simulation with the Massachusetts Department of Transportation.
These applications point to a broader opportunity: drones may help healthcare and emergency-response organizations move supplies when conventional transportation is slow or impractical. However, scaling these services will depend on operational reliability, regulatory approvals, payload requirements and the economics of drone-based delivery.
Draganfly’s medical delivery initiatives offer a potential route to diversify beyond defense, public safety and other established drone applications. Its work with Mass General Brigham provides a concrete starting point for evaluating healthcare use cases, while emergency-response initiatives broaden the potential range of customers.
Companies Benefiting from the Trend
Along with DPRO, several other drone and defense companies are also developing unmanned systems and benefiting from the trend.
EHang Holdings (EH - Free Report) : The company develops autonomous aerial vehicles for logistics and emergency medical applications. Its technology provides exposure to the broader use of autonomous aircraft for transporting goods and supporting emergency response.
Ondas Holdings (ONDS - Free Report) : Develops autonomous drone and robotic systems for industrial, public-safety and security applications.
DPRO Stock’s Earnings Estimates
The Zacks Consensus Estimate for 2026 earnings per share implies an increase of 17% year over year.
Image Source: Zacks Investment Research
DPRO Stock Trades at a Discount
In terms of valuation, DPRO’s forward 12-month price-to-sales (P/S) is 1X, a discount to the industry’s average of 2.10X.
Image Source: Zacks Investment Research
DPRO Stock’s Price Performance
In the past six months, the company’s shares have lost 28% compared with the industry’s 11.7% decline.
Image Source: Zacks Investment Research
DPRO’s Zacks Rank
The company currently has a Zacks Rank #5 (Strong Sell).
View the Zacks #1 Rank List
Image: Bigstock
Can Draganfly Turn Medical Drone Delivery Into a Growth Opportunity?
Key Takeaways
Draganfly (DPRO - Free Report) is exploring medical drone delivery as an application for its UAV technology, targeting the logistical challenges healthcare providers face. Drone-based delivery offers an alternative for transporting selected medical items between healthcare facilities and patients.
In January 2024, Draganfly announced an agreement with Mass General Brigham to pilot drone delivery services for its Home Hospital program. The initiative focused on developing delivery routes in the greater Boston area and evaluating how drones could support home-based care. Potential deliveries include critical medicines, technical equipment and laboratory materials. In December 2024, Draganfly announced the completion of initial proof-of-concept flights, marking an early step in assessing the technology’s potential for healthcare logistics.
Beyond hospital-based delivery, Draganfly also pursued medical drone applications in emergency and humanitarian settings. Its medical response technology has been associated with initiatives in Ukraine, where drones can help transport essential supplies to difficult-to-access locations. The company has also demonstrated medical delivery capabilities in an emergency-response simulation with the Massachusetts Department of Transportation.
These applications point to a broader opportunity: drones may help healthcare and emergency-response organizations move supplies when conventional transportation is slow or impractical. However, scaling these services will depend on operational reliability, regulatory approvals, payload requirements and the economics of drone-based delivery.
Draganfly’s medical delivery initiatives offer a potential route to diversify beyond defense, public safety and other established drone applications. Its work with Mass General Brigham provides a concrete starting point for evaluating healthcare use cases, while emergency-response initiatives broaden the potential range of customers.
Companies Benefiting from the Trend
Along with DPRO, several other drone and defense companies are also developing unmanned systems and benefiting from the trend.
EHang Holdings (EH - Free Report) : The company develops autonomous aerial vehicles for logistics and emergency medical applications. Its technology provides exposure to the broader use of autonomous aircraft for transporting goods and supporting emergency response.
Ondas Holdings (ONDS - Free Report) : Develops autonomous drone and robotic systems for industrial, public-safety and security applications.
DPRO Stock’s Earnings Estimates
The Zacks Consensus Estimate for 2026 earnings per share implies an increase of 17% year over year.
Image Source: Zacks Investment Research
DPRO Stock Trades at a Discount
In terms of valuation, DPRO’s forward 12-month price-to-sales (P/S) is 1X, a discount to the industry’s average of 2.10X.
Image Source: Zacks Investment Research
DPRO Stock’s Price Performance
In the past six months, the company’s shares have lost 28% compared with the industry’s 11.7% decline.
Image Source: Zacks Investment Research
DPRO’s Zacks Rank
The company currently has a Zacks Rank #5 (Strong Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.